Ridgeline FIT sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration. Full disclaimer.
$139.99
Tesamorelin is a synthetic 44–amino-acid analogue of human growth hormone–releasing hormone (GHRH), featuring an N-terminal trans-3-hexenoic acid modification that enhances its stability and receptor affinity. It examined in laboratory models for GHRH receptor signaling and pulsatile pathway analysis, making it a powerful research tool for examining pituitary signaling, metabolic regulation, and body composition responses.
Tesamorelin comprises the 44–residue GHRH peptide sequence with a trans-3-hexenoic acid moiety attached to the N-terminal tyrosine. Its molecular formula is approximately C₂₂₁H₃₆₆N₇₂O₆₇S, and molecular weight is around 5,136 Da, as recorded in PubChem (CID 146681838).
What Are the Effects of Tesamorelin (10MG)?
Endogenous GH–IGF-1 Axis Activation:
Tesamorelin binds pituitary GHRH receptors, leading to studied in experimental systems for GH/IGF-1 signaling pathways; this activation preserves natural feedback loops while avoiding supraphysiologic GH surges.
In obese subjects, a 12-month treatment correlating increases in IGF-1 with examined in metabolic pathway studies for associations with mitochondrial signaling and oxidative capacity.
preclinical and translational studies have reported modulation of adipose and metabolic signaling pathways over 26–52 weeks, along with enhanced lipid metabolism and liver fat clearance.
Tesamorelin has been shown to examined in laboratory models for glucose and lipid signaling regulation in individuals with fat accumulation syndromes.
Current investigation extends its use to study applied in experimental research contexts including aging, muscle biology, and neuroendocrine signaling in preclinical and clinical mode
Reviews
There are no reviews yet.